Particle Sciences Joins With Hapten | Chemical & Engineering News
Volume 92 Issue 5 | p. 13 | Concentrates
Issue Date: February 3, 2014

Particle Sciences Joins With Hapten

Department: Business
Keywords: pharmaceuticals, vaccines, poison ivy, dermatitis
[+]Enlarge
Credit: Shutterstock
Poison ivy
 
Credit: Shutterstock

Hapten Sciences and Particle Sciences are working together to move Hapten’s poison ivy, oak, and sumac therapy into clinical trials. According to Memphis-based Hapten, its injectable small-molecule therapy acts like a vaccine to lessen or eliminate contact dermatitis caused by exposure to urushiol oil in the plants. Particle Sciences will manufacture the therapy, which contains urushiol derivatives, for Phase I/II clinical studies scheduled for this year.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment